113 results
Page 2 of 6
6-K
EX-99.2
3u605os9
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.1
zl0rknnxrp9g7my0dh3u
10 Aug 22
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
4:31pm
SUPPL
bldon71g
15 Jul 22
Supplemental materials (foreign)
7:01am
SUPPL
f4gr 5cvl5kp3
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.1
k2gcq1ewvc1lwdbe0
12 Jul 22
Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough
7:27am
6-K
EX-99.1
vdyccou sy9d
5 Jul 22
BELLUS Health to Participate in the William Blair Biotech Focus Conference
7:00am
6-K
EX-99.1
tgonhap 6i
1 Jun 22
BELLUS Health to Participate in the Jefferies Healthcare Conference
7:00am
6-K
EX-99.1
rrgo706pzvs
11 May 22
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
5:23pm
6-K
EX-99.2
04iy8m
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.1
z9g7jy1t3b fyhatp94i
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.1
naqyj
2 May 22
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference
7:00am
6-K
EX-99.1
dsd1kz90uto6o
25 Apr 22
BELLUS Health to Participate in Multiple Upcoming Investor Conferences
4:02pm
6-K
EX-99.2
ypdaf10jmmy rd70j2x4
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
2y9i146 9of
5 Apr 22
Current report (foreign)
4:07pm
6-K
EX-99.1
p6bd3nfumds2p
1 Mar 22
BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference
7:00am
40-F
EX-99.3
7n26w5rbscg4r
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.1
hlx4w0rhi 4vthjwn
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.2
k3bwzus4ctfy
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.1
urtw x0nu6c3ic
23 Feb 22
BELLUS Health Reports Year 2021 Financial Results and Business Highlights
4:01pm
6-K
EX-99.1
uyh4q
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am